Project Grant R01HD112424

Award Date 7/1/24
Completion Date 3/31/29
Dollars Obligated $1.5M
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Farmington, CT 06032, USA
Similar Awards
This $643,049 Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to develop a physiomimetic (tissue-engineered) model of the endometrioma lesion microenvironment. The project's objective is to investigate the processes responsible for the initiation and invasion of endometriosis lesions, which could inform the design of effective therapeutic strategies....
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $584,074 to the University of Massachusetts Medical School (UMass Medical) for research on ion channels critical for uterine contraction, reproduction, and adenomyosis. The key objectives are to: Investigate the roles of the L-type calcium channel subunits Cav1.2 and Cav1.3 in calcium signaling,...
The National Institute of Child Health and Human Development (NICHD) awarded a $411,125 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to Syracuse University to develop a microfluidic human placenta organoid model. The goal is to generate human trophoblast stem cells (HTSCs) from induced pluripotent stem cells and use them to create a placenta organoid system that can replicate early/mid-gestation placental development. The researchers will study the role of...
The National Institute of Child Health and Human Development awarded a $2,163,115 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to The University of Texas Health Science Center at San Antonio to conduct research on the genetic mechanisms underlying endometriosis severity. The project aims to characterize the epigenomic landscape of low and high-stage endometriosis using single-cell multi-omics methods, dissect allele-specific gene regulation mechanisms, and...
This National Science Foundation (NSF) Engineering (CFDA 47.041) Project Grant award to Worcester Polytechnic Institute (WPI) in the amount of $259,570 will develop 3D spheroid models using patient-derived trophoblast cells to investigate placental cell invasion and study preeclampsia, a pregnancy complication with high global maternal and infant mortality rates. The 2-year project will design culture conditions to maintain the spheroid models, engineer an extracellular matrix to mimic the...
This federal Project Grant award, totaling $456,251.00, was provided by the National Institute of Child Health and Human Development under the Child Health and Human Development Extramural Research program (CFDA 93.865). The overarching goal of the proposed research is to test the hypothesis that pro-inflammatory mediators produced by maternal adipose tissue (leptin) reduce pro-angiogenic immune cells and factors at the maternal-fetal interface, which can contribute to adverse pregnancy outcomes...
The National Institute of Child Health and Human Development (NICHD) has awarded a $423,985 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to the University of Illinois to develop a novel non-invasive monitoring system for detecting placental dysfunction and associated pregnancy complications. The funding will support research to utilize extracellular vesicles (EVs) circulating in maternal blood as biomarkers, using a "target recycling...
This federal Project Grant award of $308,526.00 from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research Program (CFDA 93.837), aims to develop a novel device for uterine hemostasis (stoppage of bleeding) after cesarean section procedures. The funded project seeks to finalize design parameters, validate materials, and conduct functional performance testing for this novel system, with the goal of enabling an early feasibility trial. Cesarean...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $1,723,657 to the University of California, Los Angeles (UCLA) to investigate the regulation of X-chromosome dosage and its impact on the feto-maternal interface within the placenta. The key objectives of this 5-year research project are to: 1) define the role of the XIST B-repeat in...
This federal Project Grant award from the National Institute of Child Health and Human Development (NICHD), under CFDA Program 93.865 (Child Health and Human Development Extramural Research), provides $250,500.00 to Cedars-Sinai Medical Center to conduct research on the role of the metabolite L-kynurenine in the pathogenesis of preeclampsia in mouse models with impaired renal reserve. The research aims to understand the mechanisms by which deficiency of L-kynurenine during pregnancy...

DYSREGULATION OF ENDOMETRIAL INVASIBILITY PROXIMAL TO UTERINE SCAR AS A MECHANISM OF PLACENTA ACCRETA - ABSTRACT PLACENTA ACCRETA IS A SERIOUS MATERNAL CONDITION AFFECTING MORE THAN 1 IN 300 WOMEN IN THE US, AND RAPIDLY INCREASING IN FREQUENCY. ACCRETA IS CHARACTERIZED BY THE PLACENTA INVADING TOO DEEPLY INTO THE UTERUS, NECESSITATING HYSTERECTOMY UPON PARTURITION. THE MAJOR CORRELATE OF ACCRETA (OR INCRETA, OR PERCRETA) IS THE PRESENCE OF PREVIOUS UTERINE SCAR, MOSTLY DUE TO CAESARIAN SURGERY, ALTHOUGH THE DISEASE COULD MANIFEST WITHOUT PREVIOUS SCARS. VERY LITTLE IS UNDERSTOOD ABOUT THE CELLULAR AND MOLECULAR MECHANISMS UNDERLYING THIS DISEASE, LEAVING LIMITED THERAPEUTIC AVENUES TO PURSUE. OUR OVERALL HYPOTHESIS STATES THAT WHILE NORMAL PLACENTAL INVASION IS PREDICATED ON A FINE BALANCE OF PRO- AND ANTI-INVASABLE SIGNALING AT THE MATERNAL-FETAL INTERFACE, PLACENTA ACCRETA IS A RESPONSE OF SCAR INDUCED DYSREGULATION IN THIS SIGNALING, LEADING TO EXCESSIVE AND UN- CONTROLLED INVASION. SPECIFICALLY, WE POSIT THAT THE DYSREGULATED BIOMECHANICAL MICROENVIRONMENT AT THE SCAR TRANSFORMS DECIDUAL FIBROBLASTS INTO AN INFLAMMATORY STATE, PRODUCING CHEMOATTRACTIVE CYTOKINES RECRUITING EXTRAVILLOUS TROPHOBLASTS TOWARDS THE SCAR. WE HAVE DEVELOPED A FRAMEWORK TERMED ELI (EVOLVED LEVELS OF INVASABILITY) THAT EXPLAINS THE HIGHLY INVASIVE NATURE OF PLACENTATION IN CERTAIN MAMMALS AS PRIMARILY A STROMAL CHARACTERISTIC. BASED ON ELI FRAMEWORK, AND OUR PRELIMINARY FINDINGS, WE POSIT THAT ABERRANT MATRIX CUES FROM SCAR DYSREGULATE DECIDUAL DEFENSE, RESULTING IN UNCONTROLLED TROPHOBLAST INVASION LEADING TO ACCRETA. USING A BIOENGINEERED MODEL OF SCAR DECIDUA (HIGH RIGIDITY, HIGH COLLAGEN DENSITY, ANISOTROPIC NANOTOPOGRAPHY), WE OBSERVED DYSREGULATED MECHANORESPONSIVE SIGNALING IN DECIDUAL FIBROBLASTS (DESFS), RESULTING IN CHEMOTACTIC RECRUITMENT OF EXTRAVILLOUS TROPHOBLASTS (EVTS) TOWARDS SCAR, AS WELL AS PROMOTING EVT INVASION BY ALTERED DESF CONTRACTILITY. SPECIFICALLY, SCAR RESULTS IN HIGH ACTIVATION OF PROTEIN KINASE C BY PIEZO-1 MECHANOSENSITIVE CA2+ CHANNEL. INCREASED PKC ACTIVATION PHOSPHORYLATES NFKB, A MASTER REGULATOR OF INFLAMMATORY RESPONSE, RESULTING IN PRODUCTION OF IL-8 AND G-CSF, POTENT CHEMOATTRACTANTS FOR EVTS. IN THIS PROPOSAL, WE WILL ELUCIDATE THE MISSING LINKS IN THESE MECHANISMS USING A COMBINATION OF SPATIALLY DEFINED EXPLORATION AT TRANSCRIPTIONAL, MOLECULAR AND TISSUE LEVEL SCALES. WE HAVE DEVELOPED MANY TECHNOLOGICAL PLATFORMS SPECIFICALLY FOR UNDERSTANDING STROMAL INVASION OF TROPHOBLASTS: A MODEL OF SCAR DECIDUA THAT RECAPITULATES ACCRETA PHENOTYPE, A NANO-FABRICATED PLATFORM FOR QUANTIFICATION OF STROMAL INVASION, CELLULAR FORCE MEASUREMENT AT EVT-DESF INTERFACE, AND A MICROFLUIDIC PLATFORM TO MEASURE PARACRINE CROSS-TALK BETWEEN EVTS AND DESFS. AS ACCRETA IS A SPATIALLY DEFINED PATHOLOGY, WE WILL USE SPATIAL TRANSCRIPTOMICS IN HUMAN ACCRETA SAMPLES TO IDENTIFY CHANGES IN DECIDUAL STATE PROXIMAL TO SCAR. FINALLY, WE WILL PROFILE, AND ESTABLISH THE CAUSALITY OF PARACRINE CROSS-TALK BETWEEN DESFS AND EVTS IN ACCRETA MANIFESTATION. THIS INTEGRATED STUDY COMBINING SYSTEMS AND MECHANISTIC APPROACHES WILL SHED LIGHT TO ELUCIDATE THE BIOLOGY OF SCAR INDUCED UNCONTROLLED PLACENTAL INVASION, AND IDENTIFY TARGETS TO THERAPEUTICALLY LIMIT ACCRETA PATHOGENESIS.

Posted 6/26/24, 12:00 AM